Reporting 3rd Quarter 2023

Evonik has published its quarterly report Q3 2023 on November 7, 2023.

You can access further information here. ... MORE

Investor Relations

Circular economy: At least €1 billion in additional sales by 2030

Evonik is significantly expanding its commitment to developing solutions for the circular economy. ... MORE

Investor Relations

Evonik realigns TI division and administration

Evonik is strategically realigning two major areas to focus its resources even more on the operating businesses of its three growth divisions. ... MORE

Information about Evonik Share

Further Information

Company

Events & Presentations

Here you will find dates, information and presentations on our events. ... MORE

Company

Analysts' estimates

Evonik Industries AG is covered by German and international financial analysts, who provide their own research analyses and earnings estimates in respect of the company. ... MORE

Company

News & Reports

Here you can find "Investor Relations News" with the latest news from our company, plus our most recent interim reports, annual reports and corporate responsibility reports. ... MORE

Reporting 2023/2024

March 4, 2024

Quarterly Report Q4 2023
May 8, 2024

Quarterly Report Q1 2024
August 1, 2024

Quarterly Report Q2 2024
November 6, 2024

Quarterly Report Q3 2024

Find current Events & Presentations here

Investor Relations

Nov 14, 2023

Circular economy: At least €1 billion in additional sales by 2030

Evonik is significantly expanding its commitment to developing solutions for the circular economy. ... MORE

Investor Relations

Nov 07, 2023

Despite difficult environment: Third quarter better than second

Evonik increased the adjusted EBITDA by 8 percent to €485 million in the third quarter 2023 versus the second quarter, also thanks to strict cost discipline. ... MORE

Investor Relations

Oct 12, 2023

Evonik and Shandong Vland Biotech form JV in China with focus on gut health products for animals

Evonik China Co., Ltd and Shandong Vland Biotech Co., Ltd agreed to build a joint venture to expand their presence in gut health solutions products for farm animals globally. ... MORE

Investor Relations

Oct 05, 2023

Evonik further expands production capacity for gas separation membranes

Evonik will further expand capacity for production of its SEPURAN® hollow fiber membranes in Schörfling and Lenzing, Austria. ... MORE

Investor Relations

Sep 25, 2023

Evonik realigns TI division and administration

Evonik is strategically realigning two major areas to focus its resources even more on the operating businesses of its three growth divisions. ... MORE

Investor Relations

Aug 10, 2023

Significant profit decline in second quarter - economic environment remains difficult

Evonik posted adjusted EBITDA of €450 million in the second quarter of 2023, a slight improvement compared with the first quarter (€409 million). ... MORE

Further Information

Company

Financial data

Evonik is active in over 100 countries around the world. In fiscal 2018 more than 36,000 employees generated sales of €15 billion and an operating profit (adjusted EBITDA) of €2.6 billion. ... MORE

Company

Bonds & Rating

Evonik maintains a centralized approach to financing. Liabilities for credit and loans are fully guaranteed by Evonik Industries AG. ... MORE

Company

Key Figures Share

Here you find information about Evonik shares. ... MORE

Company

Contact & Service

You can find the contacts in the Investor Relations Department here. ... MORE

Company

Disclaimer

Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained. ... MORE

Company

Corporate Governance

As a globally active company, we have to comply with a wide range of statutory regulations and cultural standards. ... MORE

Investor Relations

Sustainable Investment (SRI)

We accept responsibility for our businesses, our employees, the environment and the society. ... MORE